Project Management in pharmaceutical industry - Revision history

S172420: /* Project management processes in pharmaceutical R&D */

2019-03-03T16:32:24Z

Project management processes in pharmaceutical R&D

← Older revision		Revision as of 16:32, 3 March 2019
Line 82:		Line 82:

	Project management team manager follows a set of interrelated actions in order to provide the desired deliverable, and a good practice and framework is given by the PMBOK guide.<ref name="PMBOK"> "Project Management Institute. ''A guide to the project management body of knowledge''. 5th edition. - Available at: http://dinus.ac.id/repository/docs/ajar/PMBOKGuide_5th_Ed.pdf" </ref> where the five categories known as Project Management Process Groups are described as follows:		Project management team manager follows a set of interrelated actions in order to provide the desired deliverable, and a good practice and framework is given by the PMBOK guide.<ref name="PMBOK"> "Project Management Institute. ''A guide to the project management body of knowledge''. 5th edition. - Available at: http://dinus.ac.id/repository/docs/ajar/PMBOKGuide_5th_Ed.pdf" </ref> where the five categories known as Project Management Process Groups are described as follows:

	~~<ol>~~
	~~<li> '''Initiation:''' Processes that define a new project or a new phase of an existing project and the authorization to initiate the project or phase~~
	~~<li> '''Planning:''' Processes to develop the scope of the project that clarifies future decision-making in order to attain the objectives.~~
	~~<li> '''Execution:''' Processes initiated in order to complete the work~~
	~~<li> '''Controlling:''' Processes to to maintain, review and regulate the progress~~
	~~<li> '''Closing:''' Finalizing all activities and closing the project~~
	~~</ol>~~

	[[File:5groups.PNG\|400px\|thumb\|left\|alt text]]		[[File:5groups.PNG\|400px\|thumb\|left\|alt text]]

S172420: /* Annotated Bibliography */

2019-03-02T17:59:45Z

Annotated Bibliography

← Older revision		Revision as of 17:59, 2 March 2019
Line 169:		Line 169:

	'''Pattanaik, A. - Complexity of project management in the pharmaceutical industry'''. This article depicts the challenges and limitation about project management in pharmaceutical industry. Furthermore it scopes the critical success factors and the key roles involved in the projects.		'''Pattanaik, A. - Complexity of project management in the pharmaceutical industry'''. This article depicts the challenges and limitation about project management in pharmaceutical industry. Furthermore it scopes the critical success factors and the key roles involved in the projects.

			'''D. L. Raemdonck & B. A. Burns - Drug Development project management'''. This chapter of the book ''Pharmaceutical and Biomedical Project Management in a Changing Global Environment'' analyses project management in the context of drug development. It shows efforts, activities and stages of the development of a new drug.

	==References==		==References==
	<references/>		<references/>

S172420: /* Annotated Bibliography */

2019-03-02T17:49:46Z

Annotated Bibliography

← Older revision		Revision as of 17:49, 2 March 2019
Line 168:		Line 168:
	==Annotated Bibliography==		==Annotated Bibliography==

	'''Pattanaik, A. - Complexity of project management in the pharmaceutical industry'''. This article depicts the challenges and limitation about project management in pharmaceutical industry.		'''Pattanaik, A. - Complexity of project management in the pharmaceutical industry'''. This article depicts the challenges and limitation about project management in pharmaceutical industry. Furthermore it scopes the critical success factors and the key roles involved in the projects.

	==References==		==References==
	<references/>		<references/>

S172420: /* Annotated Bibliography */

2019-03-02T17:47:36Z

Annotated Bibliography

← Older revision		Revision as of 17:47, 2 March 2019
Line 168:		Line 168:
	==Annotated Bibliography==		==Annotated Bibliography==

	''Pattanaik, A. - Complexity of project management in the pharmaceutical industry''. This article depicts the challenges and limitation about project management in pharmaceutical industry.		'''Pattanaik, A. - Complexity of project management in the pharmaceutical industry'''. This article depicts the challenges and limitation about project management in pharmaceutical industry.

	==References==		==References==
	<references/>		<references/>

S172420: /* Annotated Bibliography */

2019-03-02T17:47:12Z

Annotated Bibliography

← Older revision		Revision as of 17:47, 2 March 2019
Line 168:		Line 168:
	==Annotated Bibliography==		==Annotated Bibliography==

			''Pattanaik, A. - Complexity of project management in the pharmaceutical industry''. This article depicts the challenges and limitation about project management in pharmaceutical industry.

	==References==		==References==
	<references/>		<references/>

S172420 at 16:23, 2 March 2019

2019-03-02T16:23:25Z

← Older revision		Revision as of 16:23, 2 March 2019
Line 165:		Line 165:
	* ''Communication'': it manages communication exchanges between the stakeholders		* ''Communication'': it manages communication exchanges between the stakeholders
	* ''Team effectiveness'': it manages team interactions, leads the meeting and strive the team to give the best.		* ''Team effectiveness'': it manages team interactions, leads the meeting and strive the team to give the best.

			==Annotated Bibliography==



	==References==		==References==
	<references/>		<references/>

S172420: /* Uncertain in the pharmaceutical industry */

2019-03-02T15:29:13Z

Uncertain in the pharmaceutical industry

← Older revision		Revision as of 15:29, 2 March 2019
Line 25:		Line 25:
	<ol>		<ol>
	<li> the drug is first and/or best in class;		<li> the drug is first and/or best in class;
	<li> ~~Resource~~ capacity and capability;		<li> resource capacity and capability;
	<li> there is a high market potential and growth opportunity.		<li> there is a high market potential and growth opportunity.
	</ol>		</ol>
Line 32:		Line 32:

	<ol>		<ol>
	<li> ~~Having~~ in-house scientific expertise and know how;		<li> having in-house scientific expertise and know how;
	<li> ~~Resource~~ capacity and capability;		<li> resource capacity and capability;
	<li> ~~Budgetary~~ constraints that will guide trade-offs.		<li> budgetary constraints that will guide trade-offs.
	</ol>		</ol>

S172420: /* Abstract */

2019-03-02T15:24:22Z

Abstract

← Older revision		Revision as of 15:24, 2 March 2019
Line 9:		Line 9:
	In general, it takes 10 to 15 years to launch a new product in the market.<ref name="ComplexPM"> "Pattanaik, A.''Complexity of project management in the pharmaceutical industry.'' Paper presented at PMI® Global Congress 2014—EMEA, Dubai, United Arab Emirates. Newtown Square, PA: Project Management Institute. - Available at: https://www.pmi.org/learning/library/project-management-complexity-pharmaceutical-industry-1487 " </ref> The activities related to the launch require coordination between many different stakeholders both internally as R&D, regulatory, legal, finance, supply chain, sales, and marketing, and externally with partners . It is therefore really important to get these activities coordinated in an efficient way and have transparency in all the steps. During this period of uncertainty a lot of things can happen and this makes the planning part of the project even more difficult. The company then has to take decision and adjust the plans along the process. It is considerably important to evaluate all the threats, and the risks must be treated in an effective and timely manner. The complexity would otherwise increase and the project becomes cost prohibitive.		In general, it takes 10 to 15 years to launch a new product in the market.<ref name="ComplexPM"> "Pattanaik, A.''Complexity of project management in the pharmaceutical industry.'' Paper presented at PMI® Global Congress 2014—EMEA, Dubai, United Arab Emirates. Newtown Square, PA: Project Management Institute. - Available at: https://www.pmi.org/learning/library/project-management-complexity-pharmaceutical-industry-1487 " </ref> The activities related to the launch require coordination between many different stakeholders both internally as R&D, regulatory, legal, finance, supply chain, sales, and marketing, and externally with partners . It is therefore really important to get these activities coordinated in an efficient way and have transparency in all the steps. During this period of uncertainty a lot of things can happen and this makes the planning part of the project even more difficult. The company then has to take decision and adjust the plans along the process. It is considerably important to evaluate all the threats, and the risks must be treated in an effective and timely manner. The complexity would otherwise increase and the project becomes cost prohibitive.

	This article ~~defined uncertain and~~ identifies challenges in project management in the pharmaceutical research and development, describing the critical factors, different approaches, key ~~roles~~ and helps to identify ways of dealing with these challenges.		This article identifies challenges and limitations in project management in the pharmaceutical research and development, describing the critical factors, different approaches, the key role of the project manager and helps to identify ways of dealing with these challenges.

	== Challenges and Limitations in R&D Project Management ==		== Challenges and Limitations in R&D Project Management ==

S172420: /* Stakeholders */

2019-02-28T14:45:43Z

Stakeholders

← Older revision		Revision as of 14:45, 28 February 2019
Line 165:		Line 165:
	* ''Communication'': it manages communication exchanges between the stakeholders		* ''Communication'': it manages communication exchanges between the stakeholders
	* ''Team effectiveness'': it manages team interactions, leads the meeting and strive the team to give the best.		* ''Team effectiveness'': it manages team interactions, leads the meeting and strive the team to give the best.

	~~== Stakeholders ==~~

	Due to the length of the project the stakeholders change over time and they are both internal and external. It is really important to keep a good and transparent communication with them in order to minimizing the risks: in fact, information from one functional group impacts progress of another functional group. Proactive communication should be encouraged at every level to prevent any confusion and unnecessary rework.

	==References==		==References==
	<references/>		<references/>

S172420: /* Challenges in R&D Project Management */

2019-02-28T14:45:19Z

Challenges in R&D Project Management

← Older revision		Revision as of 14:45, 28 February 2019
Line 11:		Line 11:
	This article defined uncertain and identifies challenges in project management in the pharmaceutical research and development, describing the critical factors, different approaches, key roles and helps to identify ways of dealing with these challenges.		This article defined uncertain and identifies challenges in project management in the pharmaceutical research and development, describing the critical factors, different approaches, key roles and helps to identify ways of dealing with these challenges.

	== Challenges in R&D Project Management ==		== Challenges and Limitations in R&D Project Management ==

	Project Management in pharmaceutical R&D represents a key element which knowledge is a must in order to deliver to the market new product in an effective, economic and timely manner. It generally takes 10 to 15 years to launch one new product to the market.<ref name="ComplexPM"/> During this time it is required a lot of coordination between different stakeholders that usually have different priorities and backgrounds. The alignment throughout all the chain, from the initial idea to the sales, therefore needs a systematic and formalized project management approach for coordination, planning, scheduling, overseeing in the execution, and risk management.<ref name="drugDevelop"/>		Project Management in pharmaceutical R&D represents a key element which knowledge is a must in order to deliver to the market new product in an effective, economic and timely manner. It generally takes 10 to 15 years to launch one new product to the market.<ref name="ComplexPM"/> During this time it is required a lot of coordination between different stakeholders that usually have different priorities and backgrounds. The alignment throughout all the chain, from the initial idea to the sales, therefore needs a systematic and formalized project management approach for coordination, planning, scheduling, overseeing in the execution, and risk management.<ref name="drugDevelop"/>